Shingles Vaccine Market Industry Analysis and Forecast (2021-2027) Trends, Dynamics, Statistics and Segmentation by Product and Application.

Shingles Vaccine Market size was valued at US$ 1.80 Bn. in 2020 and the total revenue is expected to grow at CAGR 7 % through 2021 to 2027, reaching nearly US$ 2.89Bn.

Shingles Vaccine Market Overview:

Shingles is a disease caused by the virus known as varicella-zoster. Shingles is the reactivation of chickenpox in human body, which can cause painful rash. There has been rising prevalence of shingles among the adults and aging population around the world. There are two shingle vaccine available in the market i.e. Zostavax and Shingrix. The risk involving with these vaccine in a majority of the cases are reported among people over the age of 40 years. One key aspect driving the global market's overall growth is the increasing number of official recommendations for the use of these vaccinations. Furthermore, the growing number of senior individuals is predicted to fuel an ever-expanding industry. Many firms have spent a significant amount of money on research and development in order to create new shingles vaccines. Shingles Vaccine MarketTo know about the Research Methodology :- Request Free Sample Report 2020 is considered as a base year to forecast the market from 2021 to 2027. 2020’s market size is estimated on real numbers and outputs of the key players and major players across the globe. Past five years trends are considered while forecasting the market through 2027. 2020 is a year of exception and analyzed specially with the impact of lockdown by region.

Shingles Vaccine Market Dynamics:

The government has become more aware of shingles, particularly in developing countries, where most people are unaware of the harmful effects of shingles and how to cure them. As a result, governments in these countries have expanded their investments in shingles prevention in multiple regions. This is a critical aspect driving the market's expansion. Another of the key factors driving the market growth is the growing number of active government recommendations and efforts for the use of shingles vaccinations. Apart from that, the market is predicted to develop due to the growing senior population and the increased prevalence of shingles. Several businesses are pouring money into research and development in order to bring new shingles vaccines to market. It's also leading to an increase in FDA approvals for new products. Among adults there is 60-69 % who had received shingle vaccine increased from 6.7% in 2018 to 56% in the year 2021. Among age 70 and over the percentage who had received shingle vaccine increase from 7.8% in 2019 to 39.8% in the by the end of 2027. According to Center for Disease Control and Prevention (CDS) 34.9% of the population was obese and annual medical cost of obesity treatment was around US$ 147Bn in 2019.Technological development in the counties such as China, Japan and India are contributing to the market growth. The Shingle vaccine are available commercially in the form of recombinant vaccine. Besides, the government of several countries are taking initiatives, such as organizing free vaccine program and creating awareness to prevent shingles.Recent data from CDC has been revealed that shingle vaccine rate is increasing in the US. By almost 35% surpassing the agency’s Healthy People 2020 target of 30%.

Shingles Vaccine Market Segment Analysis:

The Shingles Vaccine Market is segmented By Product Type, By Application Based on the Product Type, The Shingles Vaccine Market is segmented into Shingrix, Zostavax. The segment dominated the market growth with largest market share of 54% in the year 2020 and it’s expected to grow at the CAGR 5.4% during the forecast period. Zostavax segment has generated $668 million of revenue in the year 2020.This vaccine used for adults 50 years of age and above. The trials of the Zostavax vaccine demonstrated that the vaccine was 64% effective in people aged 60 to 69 years. The effectiveness reduces with increasing age that is to 41% for the 70–79 age group, and 18% for those 80 years of age and above. Shingrix, segment is expected to reach revenue of 5.4Bn during the forecasting period. This vaccine is used for adults aged in 18 years and old. Shingrix is a recombinant zoster vaccine and Zostavax is live vaccine. Shingrix is injected into the muscle while Zostavax is injected underneath the skin. Shingles Vaccine Market by Product Based on the Application, The Shingles Vaccine Market is segmented into Paediatric Patients, Adult Patients. The paediatric patients are mostly suffering from the chicken pox disease. The safety and efficacy of Shingrix in individuals younger than 18 years have not been established. Shingles Vaccine has been prevented 35% paediatric patients with high efficacy. Adult Patients are getting mildly affected by the Shingles Vaccine. The vaccine is 65% effective in people aged 50 and above. Zostavax has highly recommended for pediatrc patients because of their efficacy and mild side effect such as Redness, soreness, swelling, or itching and headache. Shingles Vaccine Market by Application

Shingles Vaccine Market Regional Insights:

North America dominated the Shingles Vaccine Market with the largest market share of 55 % in 2020.It is also expected to register at CAGR of 8.6 % during the forecast period. A rise in geriatric population is a key factor responsible for the market growth. According to population predictions from the United States Census Bureau, the number of Americans aged 65 and more will increase to approximately 95 million by 2060, up from 52 million in 2019. Furthermore, the people aged 65 and up is expected to climb from 16% to 23% during forecast period. The market is being driven by rising healthcare expenditure and the adoption of modern healthcare facilities. For example, according to CMS.goverment, healthcare spending in the United States increased by 4.6% in 2019, reaching USD 3.8 trillion per person, accounting for 17.7% of the country's GDP. Aditionally, favorable reimbursement policies for emergency and non-emergency medical services in the United States and Canada are expected to contribute to market growth. Europe is anticipated to grow rapidly in this market thanks to easy accessibility of vaccine and appropriate government policies in this region. According to research Shingles Vaccine entered the Chinese market in the year 2020, GlaxoSmithKline Biological is the only manufacturer in the Chinese Shingles Vaccine market. Its annual sale value reached CNY2 million, and its annual sales volume reached 1,745 doses. The Shingles Vaccine in Asia Pacific is estimated to increase during forecast period owing to active government support and awareness about the vaccine injection among the people. The objective of the report is to present a comprehensive analysis of the Shingles Vaccine Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also helps in understanding the Shingles Vaccine Market dynamic, structure by analyzing the market segments and project the Shingles Vaccine Market size. Clear representation of competitive analysis of key players by Product, price, financial position, Product portfolio, growth strategies, and regional presence in the Shingles Vaccine Market make the report investor’s guide.

Shingles Vaccine Market Scope: Inquire before buying

Shingles Vaccine Market by Scope

Shingles Vaccine Market, by Region

• North America • Europe • Asia Pacific • South America • Middle East and Africa

Shingles Vaccine Market Major key players

• Merck & Co. Inc. • GlaxoSmithKline plc • SK Bioscience • TransMotion Medical Inc. • PfizerNovavax • Emergent BioSolutions • Inovio Pharmaceuticals • Bavarian Nordic • Mitsubishi Tanabe • Narang Medical Limited • ROYAX • Advanced Instrumentations

Frequently Asked Questions:

1] Which segments are covered in Shingles Vaccine Market report? Ans. The segments covered in Shingles Vaccine Market report are based By Product Type and Application 2] Which region is expected to hold the highest share in the Hospital Stretchers Market? Ans. North America is expected to hold the highest share in the Shingles Vaccine Market 3] What is the market size of Shingles Vaccine Market by 2027? Ans. The market size of Shingles Vaccine Market by 2027 is US $ 2.89 Bn. 4] Who are the top key players in the Hospital Stretchers Market? Ans. Merck & Co. Inc, GlaxoSmithKline plc, SK Bioscience, TransMotion Medical Inc.Pfizer, Novavax, Emergent BioSolutions, Inovio Pharmaceuticals, Bavarian Nordic, Mitsubishi Tanabe 5] What was the market size of Shingles Vaccine Market in 2020? Ans. The market size of Shingles Vaccine Market in 2020 was US $ 1.80 Bn.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Shingles Vaccine Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2020 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Shingles Vaccine Market 3.4. Geographical Snapshot of the Shingles Vaccine Market , By Manufacturer share 4. Shingles Vaccine Market Overview, 2020-2027 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Shingles Vaccine Market 5. Supply Side and Demand Side Indicators 6. Shingles Vaccine Market Analysis and Forecast, 2020-2027 6.1. Shingles Vaccine Market Size & Y-o-Y Growth Analysis. 7. Shingles Vaccine Market Analysis and Forecasts, 2020-2027 7.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 7.1.1. Shingrix, 7.1.2. Zostavax 7.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 7.2.1. Pediatric Patients 7.2.2. Adult Patients 8. Shingles Vaccine Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2020-2027 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Shingles Vaccine Market Analysis and Forecasts, 2020-2027 9.1. Market Size (Value) Estimates & Forecast By Product Type, 2020-2027 9.1.1. Shingrix, 9.1.2. Zostavax 9.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 9.2.1. Pediatric Patients 9.2.2. Adult Patients 10. North America Shingles Vaccine Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2020-2027 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Shingles Vaccine Market Analysis and Forecasts, 2020-2027 11.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 11.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 12. Canada Shingles Vaccine Market Analysis and Forecasts, 2020-2027 12.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 12.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 13. Mexico Shingles Vaccine Market Analysis and Forecasts, 2020-2027 13.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 13.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 14. Europe Shingles Vaccine Market Analysis and Forecasts, 2020-2027 14.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 14.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 15. Europe Shingles Vaccine Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2020-2027 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Shingles Vaccine Market Analysis and Forecasts, 2020-2027 16.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 16.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 17. France Shingles Vaccine Market Analysis and Forecasts, 2020-2027 17.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 17.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 18. Germany Shingles Vaccine Market Analysis and Forecasts, 2020-2027 18.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 18.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 19. Italy Shingles Vaccine Market Analysis and Forecasts, 2020-2027 19.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 19.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 20. Spain Shingles Vaccine Market Analysis and Forecasts, 2020-2027 20.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 20.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 21. Sweden Shingles Vaccine Market Analysis and Forecasts, 2020-2027 21.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 21.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 22. CIS Countries Shingles Vaccine Market Analysis and Forecasts, 2020-2027 22.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 22.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 23. Rest of Europe Shingles Vaccine Market Analysis and Forecasts, 2020-2027 23.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 23.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 24. Asia Pacific Shingles Vaccine Market Analysis and Forecasts, 2020-2027 24.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 24.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 25. Asia Pacific Shingles Vaccine Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates &Forecast By Country, 2020-2027 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Shingles Vaccine Market Analysis and Forecasts, 2020-2027 26.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 26.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 27. India Shingles Vaccine Market Analysis and Forecasts, 2020-2027 27.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 27.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 28. Japan Shingles Vaccine Market Analysis and Forecasts, 2020-2027 28.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 28.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 29. South Korea Shingles Vaccine Market Analysis and Forecasts, 2020-2027 29.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 29.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 30. Australia Shingles Vaccine Market Analysis and Forecasts, 2020-2027 30.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 30.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 31. ASEAN Shingles Vaccine Market Analysis and Forecasts, 2020-2027 31.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 31.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 32. Analysis and Forecasts, 2020-2027 32.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 32.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 33. Middle East Africa Shingles Vaccine Market Analysis and Forecasts, 2020-2027 33.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 33.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 34. Middle East Africa Shingles Vaccine Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2020-2027 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Shingles Vaccine Market Analysis and Forecasts, 2020-2027 35.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 35.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 36. GCC Countries Shingles Vaccine Market Analysis and Forecasts, 2020-2027 36.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 36.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 37. Egypt Shingles Vaccine Market Analysis and Forecasts, 2020-2027 37.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 37.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 38. Nigeria Shingles Vaccine Market Analysis and Forecasts, 2020-2027 38.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 38.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 39. Rest of ME&A Shingles Vaccine Market Analysis and Forecasts, 2020-2027 39.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 39.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 40. South America Shingles Vaccine Market Analysis and Forecasts, 2020-2027 40.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 40.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 41. South America Shingles Vaccine Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2020-2027 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Shingles Vaccine Market Analysis and Forecasts, 2020-2027 42.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 42.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 43. Argentina Shingles Vaccine Market Analysis and Forecasts, 2020-2027 43.1. Market Size (Value) Estimates & Forecast By Application, 2020-2027 43.2. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 44. Rest of South America Shingles Vaccine Market Analysis and Forecasts, 2020-2027 44.1. Market Size (Value) Estimates & Forecast By Product Type , 2020-2027 44.2. Market Size (Value) Estimates & Forecast By Application, 2020-2027 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Shingles Vaccine Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Merck.co.Inc 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. GlaxoSmithKline plc 45.3.3. SK Bioscience 45.3.4. TransMotion Medical Inc. 45.3.5. Pfizer 45.3.6. Novavax 45.3.7. Emergent BioSolutions 45.3.8. Inovio Pharmaceuticals 45.3.9. Bavarian Nordic 45.3.10. Mitsubishi Tanabe 45.3.11. Narang Medical Limited 45.3.12. ROYAX. 46. Primary Key Insights

About This Report

Report ID 124937
Category Healthcare
Published Date Oct 2021
Updated Date
Contact Us